Health

Healthcare Economist Unbiased Analysis of Today’s Healthcare Issues

  • On the importance of treating mental illness and the cost of psychedelics
    by Jason Shafrin on March 5, 2026 at 6:06 am

    Treating serious mental illness is not just a good thing to do for altruistic reasons. It also can improve health outcomes and reduce cost for those with comorbid physical conditions as well. Vincent Joralemon writes in Health Affairs Forefront regarding this issue. The article quotes Sherry Rais, CEO of Enthea: Ten percent of patients drive…

  • Real world experience with insurers pushing back on copay cards
    by Jason Shafrin on March 4, 2026 at 7:24 am

    As reported by Kaiser Health News: The value of drugmakers’ copay cards has become more unpredictable as insurers try to restrict their use. Many insurance plans, for instance, do not count the money from a copay program toward a patient’s deductible.And patients who use a copay card can wind up paying full or nearly full price…

  • Impact of Private Equity on Dentists
    by Jason Shafrin on March 3, 2026 at 5:32 am

    From a recent paper by Nasseh et al. 2026 in Health Services Research: Following acquisition, private equity-owned dental offices increased charges for dental care services by 3.3% (95% CI: 2.3%–4.4%), although allowed prices for these services remained statistically unchanged. Dental offices acquired by private equity firms tended to shift from diagnostic and preventive procedures to…

  • What is are the health and economic impacts of declining vaccination rates?
    by Jason Shafrin on February 26, 2026 at 2:40 am

    VaxImpactMap is an interesting online tool that quantifies the health and economic costs of declining childhood vaccination. The tool was developed by Mahmud Sheku, Connor Van Meter, Robert Bednarczyk, and Ben Lopman at Emory University Rollins School of Public Health. The tool focuses on changes these outcomes for three vaccine preventable diseases: Rotavirus, Pertussis (Whooping…

  • Which types of health insurers make the most money?
    by Jason Shafrin on February 24, 2026 at 2:47 am

    It turns out the answer is Medicare Advantage plans according to a KFF analysis released today. However the reason why Medicare Advantage is more profitable may not be obvious: At the end of 2024, gross margins per enrollee ranged from $608 in the Medicaid managed care market to $1,655 in the Medicare Advantage market. Gross…